vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
30.46
0.00 (0.00%)
At close: Sep 16, 2026, 4:00 PM EDT
30.28
-0.18 (-0.59%)
After-hours: Sep 16, 2026, 6:13 PM EDT
vTv Therapeutics Revenue
Revenue (ttm)
$36.84M
Revenue Growth
+216,600.00%
P/S Ratio
10.27
Revenue / Employee
$1,416,885
Employees
26
Market Cap
378.46M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 1.02M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 2.02M | -1.99M | -49.61% |
| Dec 31, 2021 | 4.01M | -2.41M | -37.56% |
| Dec 31, 2020 | 6.41M | 3.65M | 132.05% |
| Dec 31, 2019 | 2.76M | -9.67M | -77.77% |
| Dec 31, 2018 | 12.43M | 12.14M | 4,172.85% |
| Dec 31, 2017 | 291.00K | -343.00K | -54.10% |
| Dec 31, 2016 | 634.00K | 115.00K | 22.16% |
| Dec 31, 2015 | 519.00K | -1.03M | -66.49% |
| Dec 31, 2014 | 1.55M | 573.00K | 58.71% |
| Dec 31, 2013 | 976.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
VTVT News
- 12 hours ago - vTv Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 1 day ago - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 14 days ago - vTv Therapeutics to Participate in September Investor Conferences - GlobeNewsWire
- 14 days ago - vTv Therapeutics initiated with an Outperform at LifeSci Capital - TheFly
- 5 weeks ago - vTv Therapeutics price target lowered to $42 from $45 at H.C. Wainwright - TheFly
- 5 weeks ago - vTv Therapeutics reports Q2 EPS ($1.05), consensus (99c) - TheFly
- 5 weeks ago - vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - vTv Therapeutics Quarterly report: Q2 2026 - Filings